Drug insight: cyclo-oxygenase 2 inhibitors and cardiovascular risk--where are we now?
about
The Pathway Less Traveled: Moving from Candidate Genes to Candidate Pathways in the Analysis of Genome-Wide Data from Large Scale Pharmacogenetic Association Studies.Chronic inflammation in cancer development.Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors.Implants for total hip arthroplasty.Drug-induced immunomodulation to affect the development and progression of atherosclerosis: a new opportunity?Cox-dependent fatty acid metabolites cause pain through activation of the irritant receptor TRPA1.Non-steroidal anti-inflammatory drug use does not appear to be associated with increased cardiovascular mortality in patients with inflammatory polyarthritis: results from a primary care based inception cohort of patients.Cardiovascular effects of noncardiovascular drugs.The cyclooxygenase site, but not the peroxidase site of cyclooxygenase-2 is required for neurotoxicity in hypoxic and ischemic injury.Prolonged opportunity for neuroprotection in experimental stroke with selective blockade of cyclooxygenase-2 activity.Interaction between COX-2 G-765C and smoking in relation to coronary artery disease in a Chinese Uighur population.
P2860
Q33440652-51F2CA41-6620-494F-8673-3B324C81DB8DQ35928265-EE756020-7557-4907-AF3E-D96B93F4EFEAQ36498885-FB4D5154-FEDD-4D36-944B-7759C2725E60Q36728860-0BBFD79E-FF56-47DB-BD4E-88E907853EF1Q36752124-7E6231E0-212F-4755-AB31-A8262742D525Q36954499-48794BD7-23D8-41F6-9F56-38D0F6E0023CQ37079259-205F8271-65C7-48D6-AFC6-D331D2756A71Q37413163-DA53EEEE-9B79-4735-AE90-16DE4FB05A30Q39726638-27D305A5-83F6-4A63-A004-D445D66C4801Q41982686-FDF16895-7D4E-44A5-A113-95247C4F44B9Q54401132-0B832969-46EC-4103-ACA0-BE6E60901C4C
P2860
Drug insight: cyclo-oxygenase 2 inhibitors and cardiovascular risk--where are we now?
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Drug insight: cyclo-oxygenase 2 inhibitors and cardiovascular risk--where are we now?
@ast
Drug insight: cyclo-oxygenase 2 inhibitors and cardiovascular risk--where are we now?
@en
type
label
Drug insight: cyclo-oxygenase 2 inhibitors and cardiovascular risk--where are we now?
@ast
Drug insight: cyclo-oxygenase 2 inhibitors and cardiovascular risk--where are we now?
@en
prefLabel
Drug insight: cyclo-oxygenase 2 inhibitors and cardiovascular risk--where are we now?
@ast
Drug insight: cyclo-oxygenase 2 inhibitors and cardiovascular risk--where are we now?
@en
P2860
P356
P1476
Drug insight: cyclo-oxygenase 2 inhibitors and cardiovascular risk--where are we now?
@en
P2093
Gary Spektor
P2860
P304
P356
10.1038/NCPCARDIO0214
P577
2005-06-01T00:00:00Z